Intramuscular (IM) Injection Intramuscular injection delivers peptides directly into skeletal muscle tissue, which has significantly more blood flow than subcutaneous fat
WHO World Health Organization , Use of GLP-1 analogues in the treatment of obesity, 2th December 2025 ANSM (National Agency for the Safety of Medicines and Health Products) , GLP-1 analogues: update on the monitoring of serious adverse effects and misuse Published on July 05, 2024 and updated on January 07, 2026 ANSM (National Agency for the Safety of Medicines and Health Products) , Monitoring of GLP-1 aglycones: ANSM confirms the favorable benefit/risk ratio when these drugs are used in accordance with recommendations
"I feel amazing," says Tamara Hall, 45, a mother of three
GLP-1 secretion by microglial cells and decreased CNS expression in obesity
PlexusDx providers are trained to support flexible timing and can adjust treatment plans if postpartum circumstances change unexpectedly
Scientific References Frequently Asked Questions Can I stay on the 3mg dose of Rybelsus long-term